vimarsana.com
Home
Live Updates
Diazoxide Choline Designated Breakthrough Therapy for Prader
Diazoxide Choline Designated Breakthrough Therapy for Prader
Diazoxide Choline Designated Breakthrough Therapy for Prader-Willi Syndrome
The FDA has granted Breakthrough Therapy designation to diazoxide choline for the treatment of adults and children ages 4 years and older with genetically confirmed Prader-Willi syndrome (PWS) who have hyperphagia.
Related Keywords
Manish Bhatnagar ,
Drug Administration ,
Breakthrough Therapy ,
Fast Track ,